INTERNATIONAL PATENT: LEVICEPT LIMITED FILES APPLICATION FOR "P75 NEUROTROPHIN RECEPTOR-FC FUSION PROTEIN FOR USE IN PAIN THERAPY"

GENEVA, Sept. 8 -- LEVICEPT LIMITED (Innovation HouseDiscovery ParkSandwich Kent CT13 9ND) filed a patent application (PCT/GB2025/050397) for "P75 NEUROTROPHIN RECEPTOR-FC FUSION PROTEIN FOR USE IN PAIN THERAPY" on Feb 27, 2025. With publication no. WO/2025/181485, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WESTBROOK, Simon (C/O Levicept LimitedInnovation HouseDiscovery ParkSandwich Kent CT13 9ND)

Abstract: A glycosylated p75NTR neurotrophin binding protein (NBP)-Fc fusion protein, comprising: a p75NTR(NBP) portio...